Hemab Therapeutics is likely to gain ground as its treatment for a pair of rare bleeding disorders shows signs of efficacy, per Goldman Sachs.
Credit ‘FEMO’ for driving the market higher despite Iran and other worries. Here’s what it means
Ed Yardeni argues there’s a new driver for stocks.
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, Micron, Pershing Square, Dell, Occidental & more
Here are Tuesday’s biggest calls on Wall Street.
Bill Ackman’s stock is off to a great start since its debut. But analysts are leery from here
The stock, which trades under the ticker PS, debuted alongside closed-end fund Pershing Square USA, or PSUS, on the New York Stock Exchange.
This semiconductor stock rose 700% in the past year. UBS says it still could double
Micron Technology could roughly double its share price as investors take stock of the long-term agreements that should improve its financial profile, per UBS.
These tech stocks have seen bullish ‘flag patterns’ recently, says Katie Stockton
The founder of Fairlead Strategies breaks down how this chart formation occurs.
Berkshire Hathaway’s longtime edge over S&P 500 shows signs of eroding
Technical analysts are increasingly pointing to signs that Berkshire’s shares are losing momentum relative to the S&P 500.
Want to hop off the AI trade? Goldman says buy these stocks that have nothing to do with it
Stocks such as Eli Lilly and Fortinet are less correlated to the artificial intelligence frenzy, according to Goldman Sachs.
Top Wall Street analysts like these dividend stocks for steady income
Amid ongoing uncertainty, investors seeking consistent income can consider adding dividend stocks to their portfolios.
China tech plays to ride out macro volatility
The China stock play right now is to focus on artificial intelligence-related names, regardless of the slower economic growth, several analysts said.